Zoar Limited ZOAR
Annual
Quarterly
No annual revenue total was found in ZOAR LIMITED's SEC filings.
Zoar Limited (ZOAR) files with the SEC under industry code 2834, Pharmaceutical Preparations.
Revenue
—
Net income
—
Operating cash flow
—
Free cash flow
—
EPS
—
Dividend per share
None
Shares outstanding
—
Net cash
—
Operating margin
—
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ZOAR
- Fiscal year ends
- March 31
- Incorporated in
- Cayman Islands
- Headquarters
- Kowloon
- SEC filer status
- , Emerging growth company
- SEC CIK
- 2078148
- Former names
- Dr Ashleys Ltd (until Mar 2, 2026)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.